We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP39546
Abstract: They offer promising formulation options for drugs limited by low therapeutic indexes in traditional dosage forms and current "undruggable" targets. Analytical characterization of LNPs is critical to drug design, formulation development, understanding in vivo performance, as well as quality control.Summary: Lipid nanoparticles (LNPs) have shown great success in the pharmaceutical industry, leading to 23 approved products in the U.S. and Europe over the past 30 years. References: Fan Y., et al. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery[J]. Journal of pharmaceutical and biomedical analysis, 2021, 192: 113642.
https://lipids.alfa-chemistry.com/lipid-nanoparticles-lnps-characterization.html
https://lipids.alfa-chemistry.com/lipid-nanoparticles-lnps-characterization.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Semaglutide: A Star Product In The Field of Hypoglycemic And Weight Loss
Sally Zou
Clinical Toxicity Of Antibody Drug Conjugates
Sally Zou
Targeted Drug Therapy And Immunotherapy For Breast Cancer
Sally Zou
Directions for Next Generation Antibody-Drug Conjugates
Sally Zou
Clinical Development of ADC Drugs Targeting TROP-2
Sonia Li